Retrovirology (Sep 2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

  • Borthwick NJ,
  • Ahmed T,
  • Rose A,
  • Ebrahimsa U,
  • Black A,
  • Hayton E,
  • Yang H,
  • Hancock G,
  • Campion S,
  • Frahm N,
  • Colloca S,
  • Nicosia A,
  • McMichael A,
  • Dorrell L,
  • Hanke T

DOI
https://doi.org/10.1186/1742-4690-9-S2-P118
Journal volume & issue
Vol. 9, no. Suppl 2
p. P118

Abstract

Read online

No abstracts available.